MEGZURPAZ
DEAD

Serial Number

90710106

Owner

Celgene Corporation

Attorney

Xiomara Triana

Filing Date

May 13, 2021

Add to watchlist:

No watchlists yet
View on USPTO

MEGZURPAZ Trademark

Serial Number: 90710106

MEGZURPAZ is a trademark filed by Celgene Corporation on May 13, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Celgene Corporation (883 trademarks)

7 Powder Horn Drive
Warren, NJ 07059

Entity Type: 03

Trademark Details

Filing Date

May 13, 2021

Registration Date

Not Registered

Published for Opposition

November 8, 2022

Goods & Services

Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical preparations for human use for immunotherapy, namely, T Cell therapy

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Feb 9, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 9, 2026 ABN6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Feb 9, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 9, 2026 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 11, 2025 EXRA
SOU EXTENSION 5 GRANTED
Dec 10, 2025 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 10, 2025 AITU
SOU EXTENSION 5 FILED
Jun 24, 2025 EXT5
SOU TEAS EXTENSION RECEIVED
Jun 24, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 11, 2024 EXRA
SOU EXTENSION 4 GRANTED
Dec 11, 2024 EX4G
SOU EXTENSION 4 FILED
Dec 11, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Dec 11, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 18, 2024 EXRA
SOU EXTENSION 3 GRANTED
Jun 18, 2024 EX3G
SOU EXTENSION 3 FILED
Jun 18, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 18, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 4, 2024 EXRA
SOU EXTENSION 2 GRANTED
Jan 2, 2024 EX2G
SOU EXTENSION 2 FILED
Jan 2, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 2, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 30, 2023 EXRA
SOU EXTENSION 1 GRANTED
Jun 28, 2023 EX1G
SOU EXTENSION 1 FILED
Jun 28, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 28, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 3, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 8, 2022 NPUB
PUBLISHED FOR OPPOSITION
Nov 8, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 19, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 1, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 13, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 13, 2022 CRFA
ASSIGNED TO LIE
Sep 12, 2022 ALIE
NOTICE OF REVIVAL - E-MAILED
Aug 9, 2022 NREV
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 9, 2022 TROA
PETITION TO REVIVE-GRANTED
Aug 9, 2022 PETG
TEAS PETITION TO REVIVE RECEIVED
Aug 9, 2022 PROA
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Aug 8, 2022 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Aug 8, 2022 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 25, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jan 25, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jan 25, 2022 CNRT
ASSIGNED TO EXAMINER
Jan 20, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 12, 2021 NWOS
NEW APPLICATION ENTERED
May 17, 2021 NWAP